Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)".
Press Release Aug 19 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial)
- Press Release Aug 14 2025
- Press Release Jul 10 2025
- Glenmark Launches a Transformative Nutrition and Livelihood Project in Emali, Kenya
- Press Release Jun 24 2025
Later from Glenmark Pharmaceuticals
- Q1FY 2025-26
- FY 2024-25
- Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials
- Press Release Sep 02 2025
- Press Release Sep 05 2025
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals